pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Sep 1·1 min read
save

Google Gemini adds Zocdoc booking, while Solv partners with Amazon

Sep 1, 2026·read at Endpoints ↗DealPositive

In August, Google revealed that users of its Gemini AI platform can schedule medical appointments directly through Zocdoc, integrating AI assistance with healthcare scheduling.

The move expands Gemini's consumer services into the health-tech space, offering a streamlined way for patients to find and book visits using conversational AI.

Around the same time, health-tech startup Solv announced a partnership with Amazon, further linking digital health solutions with major technology platforms.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Health Tech meets AI giants”

read at Endpoints ↗
71 words · retrieved Sep 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 12h agoMerck reports mixed data for Lucentis competitor in diabetic macular edemaEndpoints
  • 13h agoAsahi Kasei lands approval for new HSV treatmentEndpoints
  • 15h agoMirum succeeds in rare liver disease trial; First Tracks delivers in celiacEndpoints
  • 15h agoBristol Myers reveals a pair of Phase 3 wins for fibrosis, RayzeBio drugsEndpoints
  • 15h agoBrent Saunders out as Bausch + Lomb CEO, an abrupt end to three-year runEndpoints